Lot History
Retatrutide (Triple Agonist) — Certificate of Analysis History
Across 4 published lots of Retatrutide (Triple Agonist), mean HPLC purity 99.7%, mean content 112.9% of label. Every figure below is the issuing laboratory’s, published in full, and every lot links to the lab’s own verification record. A single certificate shows one batch; this page shows whether the numbers hold up lot after lot.
| Lot | Strength | Purity | Measured | Fill | Tested |
|---|---|---|---|---|---|
| RETA-CA-26F-20 | 20mg | 99.577% | 24.68 mg | 123.4% | 2026-07-21 |
| RETA-CA-26F-10 | 10mg | 99.637% | 11.76 mg | 117.6% | 2026-07-13 |
| RETA-CA-26F-40 | 40mg | 99.703% | 40.23 mg | 100.6% | 2026-07-13 |
| RETA-CA-26C-01 | 50mg | 99.82% | 54.93 mg | 109.9% | 2026-04-10 |
Research use only. Materials supplied by Eppix Labs are intended strictly for in-vitro laboratory research. Not for human or veterinary use, and not for the diagnosis, treatment, cure or prevention of any condition.